Table 2.

Baseline haematological and biochemical data stratified based on the presence (with) or absence (without) of dialysis-induced regional wall motion abnormalities (RWMAs) taken before and after HD

ParameterPredialysis blood testingPostdialysis blood testing
Patients with RWMAsPatients without RWMAsP valuePatients with RWMAsPatients without RWMAsP value
Haemoglobin (g/dl)11 ± 1.311.5 ± 10.1511.4 ± 1.412 ± 1.50.14
Haematocrit (%)36 ± 436 ± 20.3536 ± 437 ± 40.44
Na+ (mEq/L)138 ± 3139 ± 40.18138 ± 2139 ± 30.1
K+ (mEq/L)4.8 ± 0.84.7 ± 0.90.893.0 ± 0.43.0 ± 0.50.69
Urea nitrogen (mg/dl)59.1 ± 15.155.5 ± 14.00.3317.4 ± 6.217.4 ± 7.00.81
Creatinine (mgl/dl)8.8 ± 2.59.8 ± 2.90.133.4 ± 1.23.9 ± 1.70.12
Phosphorus (mg/dl)5.3 ± 1.25.0 ± 1.90.422.5 ± 0.62.5 ± 0.60.61
Bicarbonate (mEq/L)22.7 ± 3.022.8 ± 3.20.8727.8 ± 2.828.4 ± 2.50.44
Calcium (mg/dl)9.68 ± 0.69.6 ± 0.60.589.4 ± 0.49.6 ± 0.440.84
Albumin (g/dl)3.5 ± 0.43.7 ± 0.30.023.7 ± 0.53.9 ± 0.60.04
hsCRP (mg/L)1.2 ± 1.00.8 ± 0.70.13
cTnT (ng/ml)0.098 ± 0.080.036 ± 0.040.001
  • Postdialysis cardiac troponin-T (cTnT) levels were not taken due to an insufficient time lapse needed to detect a significant change. hsCRP, high sensitivity C-reactive protein.